| Aug 28 |
My Strategy For Longboard Pharmaceuticals After Its Big Run
|
| Aug 26 |
Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress
|
| Aug 26 |
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on September 16, 2024
|
| Aug 4 |
Longboard Pharmaceuticals, Inc. (LBPH) Q2 2024 Earnings Call Transcript
|
| Aug 4 |
Is Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Trading At A 40% Discount?
|
| Aug 2 |
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
|
| Aug 2 |
Longboard Pharmaceuticals GAAP EPS of -$0.56
|
| Aug 1 |
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
|
| Jul 29 |
Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1
|
| Jul 25 |
Longboard Pharmaceuticals (LBPH) Is a Great Choice for 'Trend' Investors, Here's Why
|
